Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Netarsudil vs Timolol in Elevated IOP (ROCKET-3)
NCT02246764Phase 3Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Sep 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of netarsudil in open-angle glaucoma (OAG), ocular hypertension, sponsored by Aerie Pharmaceuticals. Started Sep 2014; status: completed.
02
Drugs
netarsudil
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02246764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02246764.